Literature DB >> 21345623

[Arguments for an infectious cause of IUGR].

A-G Cordier1, S Nedellec, A Benachi, R Frydman, O Picone.   

Abstract

Intra-uterine growth retardation (IUGR) is a frequent cause of consultation in antenatal care unit. The prognosis relies on the etiology: vascular, chromosomic, genetic, or infectious. Because of chronic fetal distress, hypotrophy increase morbidity, mortality and neurosensorial long term effect. Usually, infection is involved in 5 to 15% of the IUGR, mainly by Cytomegalovirus (CMV), Varicella Zoster virus, rubella, toxoplasmosis, herpes and syphilis. Maternal sera and amniotic liquid analysis make the diagnosis possible but fetal ultrasound scan is used to find other features. Most of the abnormalities are unspecific but their combination can worsen fetal prognosis. Infection should always be ruled out in the assessment of IUGR.
Copyright © 2011. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Year:  2011        PMID: 21345623     DOI: 10.1016/j.jgyn.2011.01.001

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  3 in total

1.  [Histopathological lesions of the placenta associated with severe intrauterine growth retardation: about a clinical case].

Authors:  Hanaa Zaidi; Najat Lamalmi; Abderahmane Malihi; Amina Barkat; Zaytouna Alhamany
Journal:  Pan Afr Med J       Date:  2019-09-27

2.  A systematic review on estimating population attributable fraction for risk factors for small-for-gestational-age births in 81 low- and middle-income countries.

Authors:  Sabi Gurung; Hannah Hanzi Tong; Emily Bryce; Joanne Katz; Anne Cc Lee; Robert E Black; Neff Walker
Journal:  J Glob Health       Date:  2022-03-26       Impact factor: 4.413

3.  Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.

Authors:  Elizabeth P Schlaudecker; Flor M Munoz; Azucena Bardají; Nansi S Boghossian; Asma Khalil; Hatem Mousa; Mirjana Nesin; Muhammad Imran Nisar; Vitali Pool; Hans M L Spiegel; Milagritos D Tapia; Sonali Kochhar; Steven Black
Journal:  Vaccine       Date:  2017-12-04       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.